Type 2 diabetes mellitus prevention programs
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2011, Vol 28, Issue 4
Abstract
Type 2 diabetes mellitus (DM) is the most costly chronic disease for both the individual and society. Its micro- and macro-vascular complications constitute a major cause of morbidity and mortality. Additional genetic variants interact with various environmental factors in the development of this complex multi-genetic disorder. Various major diabetes prevention trials based on lifestyle and/or medical interventions in high-risk individuals have shown that the process of its natural history, from the preclinical phase of impaired glucose regulation to the appearance of clinical DM, can be stopped. This involves important applications in primary health care. According to the results of the prevention trials, the interventions changing dietary habits and increasing physical activity are the most effective strategies, and should be the first steps in type 2 DM prevention programs. Interventions with administration of drugs such as metformin, acarbose and orlistat also appear effective, but as a second choice, taking into account their side effects and contraindications. Many countries have begun to implement strategies for primary prevention of type 2 DM, although the cost-effectiveness of the models and strategies used have not yet evaluated. The development and implementation of national policies for the prevention of type 2 DM with optimum efficiency and minimum cost is the only way to reduce the personal and socio-economic burden of this disease and its complications.
Authors and Affiliations
M. MATTE, E. VELONAKIS
Multiple myeloma under bortezomib-based regimen and varicella-zoster virus reactivation
A 68-year-old male was presented at the Outpatient Clinic of our Department because of anemia and severe lumbar pain which deteriorated during the last two weeks despite the use of paracetamol and nimesulide. The X-ra...
Proximal occlusion of the left common carotid artery
No abstract available
Περίπτωση νόσου Weil με ανεπάρκεια πολλών οργάνων καιάριστη έκβαση
Diagnosis documentation and prognostic classification of myeloid and lymphoid neoplasms by molecular techniques
The earlier (2001) and current (2008) WHO classification of "tumours of hematopoietic and lymphoid tissues" use all available information (cytomorphology, immunophenotype, genetic features, clinical features) to define t...
Rational clinical decisions. The concept of treatment threshold
No abstract available